Showing results (91-100 of 109) with videos related to
Sort By:
Pageof 11
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 6, 2024
Receptor-Targeted Peptide Conjugates Based on Diphosphines Enable Preparation of <sup>99m</sup>Tc and <sup>188</sup>Re Theranostic Agents for Prostate CancerTruc T Pham, Ingebjørg N Hungnes, Charlotte Rivas, et al.European Radiology|February 22, 2024
Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([<sup>18</sup>F]FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancerDaniel Johnathan Hughes, Eleni Josephides, Robert O'Shea, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 20, 2021
A Phase II, Open-label study to assess safety and management change using <sup>68</sup>Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED studyAsim Afaq, Heather Payne, Reena Davda, et al.European Journal of Nuclear Medicine and Molecular Imaging|June 19, 2026
Does <sup>18</sup>F-sodium fluoride PET/CT have a role in the assessment of response to <sup>223</sup>Ra therapy in men with prostatic bone metastases?Glen M Blake, Ricardo Donners, Amelia E B Moore, et al.European Journal of Nuclear Medicine and Molecular Imaging|December 11, 2025
An explainable imaging-clinical biomarker for non-small cell lung cancer prognostication based on normalised hotspot to centroid distance and [<sup>18</sup>F]FDG PET/CT radiomicsMitchell Chen, Susan J Copley, Yidong Han, et al.Chemical Science|September 17, 2025
Maleic anhydride derived diphosphines: adaptable chelators for receptor-targeted <sup>99m</sup>Tc, <sup>64</sup>Cu and <sup>188</sup>Re radiotracersRachel E Nuttall, Ingebjørg N Hungnes, Truc T Pham, et al.Frontiers in Endocrinology|October 2, 2023
Utility of a simplified [<sup>18</sup>F] sodium fluoride PET imaging method to quantify bone metabolic flux for a wide range of clinical applicationsTanuj Puri, Michelle L Frost, Amelia E B Moore, et al.Breast (Edinburgh, Scotland)|September 20, 2024
Role of [<sup>18</sup>F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelinesDavid Groheux, Sofia C Vaz, Philip Poortmans, et al.JNCI Cancer Spectrum|October 3, 2023
Radium-223 in metastatic castration-resistant prostate cancer: whole-body diffusion-weighted magnetic resonance imaging scanning to assess responseChris Parker, Nina Tunariu, Holly Tovey, et al.Cancers|December 23, 2022
Non-Small Cell Lung Cancer (NSCLC) in Young Adults, Age < 50, Is Associated with Late Stage at Presentation and a Very Poor Prognosis in Patients That Do Not Have a Targeted Therapy Option: A Real-World StudyDaniel Johnathan Hughes, Matthaios Kapiris, Andreja Podvez Nevajda, et al.Pageof 11